🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 13 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 21/04/2017 | 65,63 | 65,86 | 64,72 | 65,12 | -0,82% | 1,73% | 206.146 |
| 20/04/2017 | 65,67 | 66,04 | 64,81 | 65,66 | +0,19% | 1,87% | 232.114 |
| 19/04/2017 | 65,92 | 66,23 | 64,39 | 65,53 | -0,28% | 2,79% | 370.614 |
| 18/04/2017 | 65,63 | 65,91 | 64,60 | 65,72 | -0,17% | 1,99% | 250.709 |
| 17/04/2017 | 65,61 | 66,43 | 65,45 | 65,83 | +0,18% | 1,50% | 170.720 |
| 13/04/2017 | 65,61 | 66,72 | 65,50 | 65,71 | +0,03% | 1,85% | 202.619 |
| 12/04/2017 | 65,88 | 66,26 | 65,30 | 65,70 | +0,02% | 1,47% | 223.939 |
| 11/04/2017 | 65,61 | 66,33 | 65,47 | 65,68 | -0,04% | 1,30% | 260.968 |
| 10/04/2017 | 66,08 | 67,12 | 65,33 | 65,71 | -0,88% | 2,71% | 279.243 |
| 07/04/2017 | 65,15 | 66,30 | 64,70 | 66,29 | +1,60% | 2,45% | 300.723 |
| 06/04/2017 | 64,88 | 65,49 | 63,98 | 65,25 | +0,44% | 2,33% | 318.997 |
| 05/04/2017 | 66,29 | 66,77 | 64,88 | 64,96 | -1,63% | 2,86% | 375.743 |
| 04/04/2017 | 65,58 | 66,50 | 65,20 | 66,04 | +0,23% | 1,99% | 298.960 |
| 03/04/2017 | 65,73 | 66,69 | 65,36 | 65,89 | -0,21% | 2,03% | 351.057 |
| 31/03/2017 | 65,88 | 66,41 | 65,15 | 66,03 | +0,55% | 1,91% | 343.202 |
| 30/03/2017 | 66,28 | 66,75 | 65,25 | 65,66 | -0,80% | 2,27% | 281.166 |
| 29/03/2017 | 65,94 | 66,92 | 65,32 | 66,19 | +0,08% | 2,44% | 367.728 |
| 28/03/2017 | 66,26 | 66,73 | 65,33 | 66,14 | -0,55% | 2,12% | 362.278 |
| 27/03/2017 | 64,78 | 66,58 | 64,78 | 66,51 | +1,75% | 2,77% | 378.789 |
| 24/03/2017 | 64,80 | 65,85 | 64,29 | 65,36 | +0,95% | 2,41% | 576.439 |
| 23/03/2017 | 64,78 | 65,45 | 64,34 | 64,75 | -0,27% | 1,71% | 395.620 |
| 22/03/2017 | 64,91 | 65,72 | 64,26 | 64,92 | +0,02% | 2,25% | 386.163 |
| 21/03/2017 | 68,25 | 68,25 | 64,62 | 64,91 | -4,39% | 5,32% | 501.579 |
| 20/03/2017 | 68,29 | 68,51 | 67,68 | 67,89 | -0,61% | 1,21% | 316.913 |
| 17/03/2017 | 67,10 | 68,75 | 66,44 | 68,31 | +0,88% | 3,44% | 944.488 |
| 16/03/2017 | 67,98 | 68,13 | 67,00 | 67,72 | -0,25% | 1,66% | 234.519 |
| 15/03/2017 | 66,61 | 68,17 | 66,38 | 67,89 | +1,95% | 2,69% | 259.365 |
| 14/03/2017 | 66,87 | 67,06 | 66,13 | 66,59 | -0,68% | 1,38% | 255.999 |
| 13/03/2017 | 67,72 | 68,32 | 66,91 | 67,04 | -1,89% | 2,08% | 308.898 |
| 10/03/2017 | 67,99 | 68,37 | 67,17 | 68,33 | +0,96% | 1,76% | 297.998 |